Naoki Tanaka

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 28

Top Venues

International journal of molecular sciences

Biomedicines

Clinical journal of gastroenterology

Hepatology research : the official journal of the Japan Society of Hepatology

Shinshu University Graduate School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shinshu University Graduate School of Medicine Oct 01 2014

Japan

Associate Professor :: Department of Metabolic Regulation

Publications

Takayuki Nimura, Daiki Aomura, Makoto Harada, Akinori Yamaguchi, Kosuke Yamaka, Takero Nakajima, Naoki Tanaka, Takashi Ehara, Koji Hashimoto, Yuji Kamijo
Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research. International journal of molecular sciences 25 (2) (2024)
Takayuki Nimura, Daiki Aomura, Makoto Harada, Akinori Yamaguchi, Kosuke Yamaka, Takero Nakajima, Naoki Tanaka, Takashi Ehara, Koji Hashimoto, Yuji Kamijo
Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research. International journal of molecular sciences 25 (2) (2024)
Takayuki Nimura, Daiki Aomura, Makoto Harada, Akinori Yamaguchi, Kosuke Yamaka, Takero Nakajima, Naoki Tanaka, Takashi Ehara, Koji Hashimoto, Yuji Kamijo
Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research. International journal of molecular sciences 25 (2) (2024)
Momoko Hayashi, Yoshibumi Kuwabara, Kuniji Ito, Yoshiaki Hojo, Fumiaki Arai, Kazuki Kamijima, Masakazu Takeiri, Xiaojing Wang, Pan Diao, Jun Nakayama, Naoki Tanaka
Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. Biomedicines 11 (2) (2023)
Momoko Hayashi, Yoshibumi Kuwabara, Kuniji Ito, Yoshiaki Hojo, Fumiaki Arai, Kazuki Kamijima, Masakazu Takeiri, Xiaojing Wang, Pan Diao, Jun Nakayama, Naoki Tanaka
Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. Biomedicines 11 (2) (2023)
Qianqian Zheng, Masaya Kawaguchi, Hayato Mikami, Pan Diao, Xuguang Zhang, Zhe Zhang, Takero Nakajima, Takanobu Iwadare, Takefumi Kimura, Jun Nakayama, Naoki Tanaka
Establishment of Novel Mouse Model of Dietary NASH Rapidly Progressing into Liver Cirrhosis and Tumors. Cancers 15 (14) (2023)
Xiaojing Wang, Liangjing Wang, Lin Geng, Naoki Tanaka, Bin Ye
Resmetirom Ameliorates NASH-Model Mice by Suppressing STAT3 and NF-κB Signaling Pathways in an RGS5-Dependent Manner. International journal of molecular sciences 24 (6) (2023)
Xiaojing Wang, Liangjing Wang, Lin Geng, Naoki Tanaka, Bin Ye
Resmetirom Ameliorates NASH-Model Mice by Suppressing STAT3 and NF-κB Signaling Pathways in an RGS5-Dependent Manner. International journal of molecular sciences 24 (6) (2023)
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Masahide Yazaki
Citrin Deficiency: Clinical and Nutritional Features. Nutrients 15 (10) (2023)
Xiaojing Wang, Liangjing Wang, Lin Geng, Naoki Tanaka, Bin Ye
Resmetirom Ameliorates NASH-Model Mice by Suppressing STAT3 and NF-κB Signaling Pathways in an RGS5-Dependent Manner. International journal of molecular sciences 24 (6) (2023)
Momoko Hayashi, Yoshibumi Kuwabara, Kuniji Ito, Yoshiaki Hojo, Fumiaki Arai, Kazuki Kamijima, Masakazu Takeiri, Xiaojing Wang, Pan Diao, Jun Nakayama, Naoki Tanaka
Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. Biomedicines 11 (2) (2023)
Makoto Harada, Takero Nakajima, Yosuke Yamada, Daiki Aomura, Akinori Yamaguchi, Kosuke Sonoda, Naoki Tanaka, Koji Hashimoto, Yuji Kamijo
Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study. Journal of clinical medicine 11 (3) (2022)
Takanobu Iwadare, Takefumi Kimura, Hideo Kunimoto, Naoki Tanaka, Shun-Ichi Wakabayashi, Tomoo Yamazaki, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Satoru Joshita, Takeji Umemura
Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD. Biomedicines 10 (11) (2022)
Naoyuki Fujimori, Takefumi Kimura, Naoki Tanaka, Tomoo Yamazaki, Taiki Okumura, Hiroyuki Kobayashi, Shun-Ichi Wakabayashi, Yuki Yamashita, Ayumi Sugiura, Jonathan Pham, Sai P Pydi, Kenji Sano, Satoru Joshita, Takeji Umemura
2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease. Hepatology research : the official journal of the Japan Society of Hepatology 52 (4) (2022)
Zhe Zhang, Pan Diao, Xuguang Zhang, Takero Nakajima, Takefumi Kimura, Naoki Tanaka
Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARα in Mice. Biomedicines 10 (7) (2022)
Fangping Jia, Xiao Hu, Takefumi Kimura, Naoki Tanaka
Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies. International journal of molecular sciences 22 (19) (2021)
Naoki Tanaka, Kazutaka Mukaiyama, Akio Morikawa, Satoshi Kawakami, Yasuyuki Ichise, Takefumi Kimura, Akira Horiuchi
Pemafibrate, a novel selective PPARα modulator, attenuates tamoxifen-induced fatty liver disease. Clinical journal of gastroenterology 14 (3) (2021)
Takefumi Kimura, Naoki Tanaka, Naoyuki Fujimori, Tomoo Yamazaki, Takahito Katsuyama, Yuichi Iwashita, Jonathan Pham, Satoru Joshita, Sai P Pydi, Takeji Umemura
Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD. Liver international : official journal of the International Association for the Study of the Liver 41 (3) (2021)
Daiki Aomura, Makoto Harada, Yosuke Yamada, Takero Nakajima, Koji Hashimoto, Naoki Tanaka, Yuji Kamijo
Pemafibrate Protects against Fatty Acid-Induced Nephropathy by Maintaining Renal Fatty Acid Metabolism. Metabolites 11 (6) (2021)
Yaping Wang, Takero Nakajima, Frank J Gonzalez, Naoki Tanaka
PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice. International journal of molecular sciences 21 (6) (2020)
Takefumi Kimura, Sai P Pydi, Jonathan Pham, Naoki Tanaka
Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD. Biomolecules 10 (10) (2020)
Shun-Ichi Wakabayashi, Takefumi Kimura, Naoki Tanaka
Acute liver failure with severe steatosis induced by mushroom. Liver international : official journal of the International Association for the Study of the Liver 40 (9) (2020)
Naoyuki Fujimori, Naoki Tanaka, Takefumi Kimura, Kenji Sano, Akira Horiuchi, Naoyuki Kato, Yoshiyuki Takahashi, Naoya Kuribayashi, Ayumi Sugiura, Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka
Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus. Clinical journal of gastroenterology 13 (1) (2019)
Xiaojing Wang, Naoki Tanaka, Xiao Hu, Takefumi Kimura, Yu Lu, Fangping Jia, Yoshiko Sato, Jun Nakayama, Kyoji Moriya, Kazuhiko Koike, Toshifumi Aoyama
A high-cholesterol diet promotes steatohepatitis and liver tumorigenesis in HCV core gene transgenic mice. Archives of toxicology 93 (6) (2019)
Shogo Takahashi, Naoki Tanaka, Tatsuki Fukami, Cen Xie, Tomoki Yagai, Donghwan Kim, Thomas J Velenosi, Tingting Yan, Kristopher W Krausz, Moshe Levi, Frank J Gonzalez
Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development. Hepatology communications 2 (12) (2018)
Michiharu Komatsu, Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Kenji Sano, Akira Horiuchi, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka
Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients. Hepatology research : the official journal of the Japan Society of Hepatology 48 (13) (2018)
Naoyuki Fujimori, Michiharu Komatsu, Naoki Tanaka, Mai Iwaya, Hajime Nakano, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Yugo Iwaya, Takashi Muraki, Yuki Ichikawa, Takefumi Kimura, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka
Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury. Clinical journal of gastroenterology 10 (5) (2017)
Takefumi Kimura, Akira Kobayashi, Naoki Tanaka, Kenji Sano, Michiharu Komatsu, Naoyuki Fujimori, Tomoo Yamazaki, Soichiro Shibata, Yuki Ichikawa, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Akira Horiuchi, Hiromitsu Mori, Shuichi Wada, Kendo Kiyosawa, Shin-Ichi Miyagawa, Eiji Tanaka
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection. Hepatology research : the official journal of the Japan Society of Hepatology 47 (5) (2016)

Naoki Tanaka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Naoki Tanaka